Company / Cash per Share
Moleculin Biotech, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$65.69
FY2025
5-year range
$1.92 / $65.69
FY2021-FY2025
Trend
+3320.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +3320% YoY in FY2025, a notable deviation from the 8-year average annual change of +1704%.
Based on SEC 10-K filings.
65.69 in FY2025 with a 5-year CAGR of +101.2%.
Improved from $12.34 to $65.69 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +101.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cash per share increased 3320.3% year-over-year.
- Lowest cash per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $65.69 | +3320.3% |
| FY2024 | $1.92 | -84.4% |
| FY2023 | $12.34 | - |
| FY2022 | - | - |
| FY2021 | $6.15 | +208.7% |
| FY2020 | $1.99 | +429.1% |
| FY2019 | $0.38 | +13.2% |
| FY2018 | $0.33 | -19.3% |
| FY2017 | $0.41 | +9659.8% |
| FY2016 | $0.00 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026